{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:06:59Z","timestamp":1790946419796,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021LZY010"],"award-info":[{"award-number":["ZR2021LZY010"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011324","name":"Qingdao University","doi-asserted-by":"publisher","award":["QYFYWZLL28154"],"award-info":[{"award-number":["QYFYWZLL28154"]}],"id":[{"id":"10.13039\/501100011324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870615"],"award-info":[{"award-number":["81870615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbrc.2024.151142","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T16:41:07Z","timestamp":1733503267000},"page":"151142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Isoquercitrin improves diabetes nephropathy by inhibiting the sodium-glucose co-transporter-2 pathway"],"prefix":"10.1016","volume":"744","author":[{"given":"Wenjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.151142_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.bbrc.2024.151142_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2024.151142_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211058856","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2024.151142_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.bbrc.2024.151142_bib5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on diabetic nephropathy: core curriculum 2018","volume":"71","author":"Umanath","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbrc.2024.151142_bib6","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2024.151142_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","article-title":"The global epidemiology of diabetes and kidney disease","volume":"25","author":"Koye","year":"2018","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.bbrc.2024.151142_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2215\/CJN.06080616","article-title":"SGLT2 inhibition in the diabetic kidney-from mechanisms to clinical outcome","volume":"12","author":"van Bommel","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2024.151142_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1463-1326.2008.00982.x","article-title":"Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug","volume":"11","author":"Idris","year":"2009","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.bbrc.2024.151142_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/13543780902766794","article-title":"Dapagliflozin: an emerging treatment option in type 2 diabetes","volume":"18","author":"Kipnes","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.bbrc.2024.151142_bib11","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice","volume":"292","author":"Wang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.151142_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MNH.0b013e32833bec06","article-title":"Sodium-glucose transport: role in diabetes mellitus and potential clinical implications","volume":"19","author":"Vallon","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbrc.2024.151142_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11892-018-0992-6","article-title":"New diabetes therapies and diabetic kidney disease progression: the role of SGLT-2 inhibitors","volume":"18","author":"Dekkers","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.bbrc.2024.151142_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41371-020-00393-4","article-title":"SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives","volume":"35","author":"Piperidou","year":"2021","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.bbrc.2024.151142_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.654557","article-title":"Sodium-glucose Co-transporter-2 inhibitors and nephroprotection in diabetic patients: more than a challenge","volume":"8","author":"Provenzano","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2024.151142_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.fct.2014.03.018","article-title":"Isoquercitrin: pharmacology, toxicology, and metabolism","volume":"68","author":"Valentov\u00e1","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2024.151142_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ptr.2403","article-title":"The opposing effects of the flavonoids isoquercitrin and sissotrin, isolated from Pterospartum tridentatum, on oral glucose tolerance in rats","volume":"22","author":"Paulo","year":"2008","journal-title":"Phytother Res."},{"key":"10.1016\/j.bbrc.2024.151142_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2018.04.015","article-title":"Isoquercetin ameliorates hyperglycemia and regulates key enzymes of glucose metabolism via insulin signaling pathway in streptozotocin-induced diabetic rats","volume":"829","author":"Jayachandran","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151142_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11033-019-05166-y","article-title":"Isoquercetin regulates SREBP-1C via AMPK pathway in skeletal muscle to exert antihyperlipidemic and anti-inflammatory effects in STZ induced diabetic rats","volume":"47","author":"Jayachandran","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2024.151142_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cbi.2019.02.017","article-title":"Isoquercetin upregulates antioxidant genes, suppresses inflammatory cytokines and regulates AMPK pathway in streptozotocin-induced diabetic rats","volume":"303","author":"Jayachandran","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2024.151142_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2024.151142_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","article-title":"A glimpse of various pathogenetic mechanisms of diabetic nephropathy","volume":"6","author":"Kanwar","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbrc.2024.151142_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986709787581897","article-title":"Therapeutic strategies in the treatment of diabetic nephropathy - a translational medicine approach","volume":"16","author":"Shah","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.151142_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbrc.2024.151142_bib25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1053\/ajkd.2003.50077","article-title":"Progression of diabetic nephropathy","volume":"41","author":"Kikkawa","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbrc.2024.151142_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11020378","article-title":"Therapeutic advances in diabetic nephropathy","volume":"11","author":"Sawaf","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2024.151142_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ndt\/gfw417","article-title":"Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes","volume":"33","author":"Furuichi","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbrc.2024.151142_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1005632012591","article-title":"Glucose transporters: structure, function and consequences of deficiency","volume":"23","author":"Brown","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2024.151142_bib29","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.ki.5002383","article-title":"Regulatory mechanisms of Na(+)\/glucose cotransporters in renal proximal tubule cells","author":"Lee","year":"2007","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.bbrc.2024.151142_bib30","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ki.2009.87","article-title":"Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications","volume":"75","author":"Bakris","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2024.151142_bib31","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00125-018-4656-5","article-title":"Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2","volume":"61","author":"Ghezzi","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2024.151142_bib32","doi-asserted-by":"crossref","first-page":"F10","DOI":"10.1152\/ajprenal.2001.280.1.F10","article-title":"Renal Na(+)-glucose cotransporters","volume":"280","author":"Wright","year":"2001","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbrc.2024.151142_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2017.07.033","article-title":"Renal glucose metabolism in normal physiological conditions and in diabetes","volume":"133","author":"Alsahli","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2024.151142_bib34","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2337\/diabetes.54.12.3427","article-title":"Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes","volume":"54","author":"Rahmoune","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2024.151142_bib35","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/ndt\/gfl175","article-title":"Renal glucose excretion as a function of blood glucose concentration in subjects with type 2 diabetes--results of a hyperglycaemic glucose clamp study","volume":"21","author":"Rave","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbrc.2024.151142_bib36","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1021\/jm990175n","article-title":"Na(+)-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring","volume":"42","author":"Tsujihara","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.151142_bib37","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/dc13-0387","article-title":"Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes","volume":"36","author":"DeFronzo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2024.151142_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2013.451","article-title":"Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?","volume":"86","author":"Gilbert","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2024.151142_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2024.151142_bib40","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cmet.2021.02.016","article-title":"A kidney perspective on the mechanism of action of sodium glucose cotransporter 2 inhibitors","volume":"33","author":"Sen","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2024.151142_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","article-title":"SGLT2i: beyond the glucose-lowering effect","volume":"19","author":"Ni","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2024.151142_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.12.027","article-title":"Renoprotective effects of sodium-glucose cotransporter-2 inhibitors","volume":"94","author":"Heerspink","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2024.151142_bib43","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jn\/130.5.1200","article-title":"Bioavailabilities of quercetin-3-glucoside and quercetin-4'-glucoside do not differ in humans","volume":"130","author":"Olthof","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbrc.2024.151142_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.fct.2003.10.006","article-title":"Evaluation of the toxicity of enzymatically decomposed rutin with 13-weeks dietary administration to Wistar rats","volume":"42","author":"Hasumura","year":"2004","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2024.151142_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.599416","article-title":"Isoquercitrin ameliorates cisplatin-induced nephrotoxicity via the inhibition of apoptosis, inflammation, and oxidative stress","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151142_bib46","doi-asserted-by":"crossref","first-page":"24318","DOI":"10.18632\/aging.202237","article-title":"Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK\/mTOR\/p70S6K signaling pathway","volume":"12","author":"Shui","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2024.151142_bib47","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s10528-022-10309-1","article-title":"Isoquercitrin induces endoplasmic reticulum stress and immunogenic cell death in gastric cancer cells","volume":"61","author":"Liu","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bbrc.2024.151142_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8060139","article-title":"Anti-anaphylactic activity of isoquercitrin (Quercetin-3-O-\u03b2-d-Glucose) in the cardiovascular system of animals","volume":"8","author":"Park","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2024.151142_bib49","first-page":"6675","article-title":"Isoquercetin ameliorates myocardial infarction through anti-inflammation and anti-apoptosis factor and regulating TLR4-NF-\u03baB signal pathway","volume":"17","author":"Ma","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2024.151142_bib50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000205582","article-title":"Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial","volume":"149","author":"Kawai","year":"2009","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.bbrc.2024.151142_bib51","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/1440-1681.12705","article-title":"Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation","volume":"44","author":"Zhang","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbrc.2024.151142_bib52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00394-013-0546-2","article-title":"Fructooligosaccharide augments benefits of quercetin-3-O-\u03b2-glucoside on insulin sensitivity and plasma total cholesterol with promotion of flavonoid absorption in sucrose-fed rats","volume":"53","author":"Phuwamongkolwiwat","year":"2014","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.bbrc.2024.151142_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/biof.5520310307","article-title":"Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside","volume":"31","author":"Panda","year":"2007","journal-title":"Biofactors"},{"key":"10.1016\/j.bbrc.2024.151142_bib54","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.fct.2010.05.065","article-title":"Fifty-two week chronic toxicity of enzymatically decomposed rutin in Wistar rats","volume":"48","author":"Tamura","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2024.151142_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154405","article-title":"Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy","volume":"113","author":"Otomo","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2024.151142_bib56","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biopha.2018.10.100","article-title":"Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats","volume":"109","author":"Oraby","year":"2019","journal-title":"Biomed. Pharmacother."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24016784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24016784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T15:58:45Z","timestamp":1735660725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24016784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"alternative-id":["S0006291X24016784"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151142","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoquercitrin improves diabetes nephropathy by inhibiting the sodium-glucose co-transporter-2 pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151142"}}